These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34926081)

  • 1. Is There a Correlation Between Patient-Reported Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) Score and MRI Findings in Axial Spondyloarthropathy in Routine Clinical Practice?
    Byravan S; Jain N; Stairs J; Rennie W; Moorthy A
    Cureus; 2021 Nov; 13(11):e19626. PubMed ID: 34926081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive correlation between inflammation on sacroiliac joint MRI and serum C-terminal telopeptide of type-I collagen in ankylosing spondylitis but not in non-radiographic axial spondyloarthritis.
    Kang KY; Jung JY; Hong YS; Ju JH; Park SH
    Clin Exp Rheumatol; 2017; 35(3):415-422. PubMed ID: 27974096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relevance of structural damage in the sacroiliac joints for the functional status and spinal mobility in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort.
    Protopopov M; Sieper J; Haibel H; Listing J; Rudwaleit M; Poddubnyy D
    Arthritis Res Ther; 2017 Oct; 19(1):240. PubMed ID: 29065931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validity and reliability of the Ankylosing Spondylitis Disease Activity Score with C-reactive protein (ASDAS-CRP) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with axial spondyloarthritis (axSpA) in Singapore.
    Kwan YH; Tan JJ; Phang JK; Fong W; Lim KK; Koh HL; Lui NL; Tan CS; Østbye T; Thumboo J; Leung YY
    Int J Rheum Dis; 2019 Dec; 22(12):2206-2212. PubMed ID: 31721427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease activity is longitudinally related to sacroiliac inflammation on MRI in male patients with axial spondyloarthritis: 2-years of the DESIR cohort.
    Navarro-Compán V; Ramiro S; Landewé R; Dougados M; Miceli-Richard C; Richette P; van der Heijde D
    Ann Rheum Dis; 2016 May; 75(5):874-8. PubMed ID: 26403689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Worse scores but similar patterns of disease activity: interpreting outcomes in women with axial spondyloarthropathy.
    Maguire S; Wilson F; Gallagher P; O'Shea FD
    Scand J Rheumatol; 2023 Mar; 52(2):142-149. PubMed ID: 35048786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between clinical disease activity and sacroiliac magnetic resonance imaging detection in axial spondyloarthropathy.
    Inan O; Aytekin E; Pekin Dogan Y; Nahit Mutlu I; Aydemir K; Oz N; Sayiner Caglar N
    Arch Rheumatol; 2024 Mar; 39(1):115-122. PubMed ID: 38774700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of active and inactive sacroiliitis in patients with ankylosing spondylitis using quantitative dynamic contrast-enhanced MRI.
    Zhang M; Zhou L; Huang N; Zeng H; Liu S; Liu L
    J Magn Reson Imaging; 2017 Jul; 46(1):71-78. PubMed ID: 27865027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The degree of spinal inflammation is similar in patients with axial spondyloarthritis who report high or low levels of disease activity: a cohort study.
    Kiltz U; Baraliakos X; Karakostas P; Igelmann M; Kalthoff L; Klink C; Krause D; Schmitz-Bortz E; Flörecke M; Bollow M; Braun J
    Ann Rheum Dis; 2012 Jul; 71(7):1207-11. PubMed ID: 22523430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of patients with ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) from a single rheumatology clinic in New Delhi.
    Malaviya AN; Kalyani A; Rawat R; Gogia SB
    Int J Rheum Dis; 2015 Sep; 18(7):736-41. PubMed ID: 26172961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-body Magnetic Resonance Imaging in Axial Spondyloarthritis: Reduction of Sacroiliac, Spinal, and Entheseal Inflammation in a Placebo-controlled Trial of Adalimumab.
    Krabbe S; Østergaard M; Eshed I; Sørensen IJ; Jensen B; Møller JM; Balding L; Madsen OR; Asmussen K; Eng G; Jørgensen NR; Pedersen SJ
    J Rheumatol; 2018 May; 45(5):621-629. PubMed ID: 29449506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey.
    Lopalco G; Venerito V; Cantarini L; Emmi G; Salaffi F; Di Carlo M; Tafuri S; Gentileschi S; Di Scala G; Nivuori M; Cacciapaglia F; Galeazzi M; Lapadula G; Iannone F
    Clin Exp Rheumatol; 2019; 37(5):762-767. PubMed ID: 31025925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spine and sacroiliac joints on magnetic resonance imaging in patients with early axial spondyloarthritis: prevalence of lesions and association with clinical and disease activity indices from the Italian group of the SPACE study.
    Lorenzin M; Ortolan A; Frallonardo P; Vio S; Lacognata C; Oliviero F; Punzi L; Ramonda R
    Reumatismo; 2016 Sep; 68(2):72-82. PubMed ID: 27608795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routine Assessment of Patient Index Data 3 score (RAPID3) correlates well with Bath Ankylosing Spondylitis Disease Activity index (BASDAI) in the assessment of disease activity and monitoring progression of axial spondyloarthritis.
    Danve A; Reddy A; Vakil-Gilani K; Garg N; Dinno A; Deodhar A
    Clin Rheumatol; 2015 Jan; 34(1):117-24. PubMed ID: 25421013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Discriminative Values of the Bath Ankylosing Spondylitis Disease Activity Index, Ankylosing Spondylitis Disease Activity Score, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Spondyloarthritis-Related Axial Arthritis.
    Tsang HHL; Chung HY
    J Clin Rheumatol; 2017 Aug; 23(5):267-272. PubMed ID: 28661926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of fatigue, pain, patient global assessment and the Bath Ankylosing Spondylitis Functional Index (BASFI) in spondyloarthropathy patients with stable disease according to the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI).
    Madsen OR
    Rheumatol Int; 2018 Mar; 38(3):425-432. PubMed ID: 29299630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The occurrence of sacroiliitis in HLA-B*35-positive patients with undifferentiated spondyloarthritis. A cross sectional MRI study.
    Šošo D; Aljinović J; Marinović I; Kojundžić SL; Jeličić EČ; Krstulović DM
    Clin Rheumatol; 2020 Aug; 39(8):2299-2306. PubMed ID: 32107663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active inflammation and structural change in early active axial spondyloarthritis as detected by whole-body MRI.
    Althoff CE; Sieper J; Song IH; Haibel H; Weiß A; Diekhoff T; Rudwaleit M; Freundlich B; Hamm B; Hermann KG
    Ann Rheum Dis; 2013 Jun; 72(6):967-73. PubMed ID: 22736088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor efficacy of TNF inhibitors in non-radiographic axial spondyloarthritis in the absence of objective signs: A bicentric retrospective study.
    Vidal C; Lukas C; Combe B; Berenbaum F; Pers YM; Jorgensen C; Sellam J; Morel J
    Joint Bone Spine; 2018 Jul; 85(4):461-468. PubMed ID: 28917996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI in predicting a major clinical response to anti-tumour necrosis factor treatment in ankylosing spondylitis.
    Rudwaleit M; Schwarzlose S; Hilgert ES; Listing J; Braun J; Sieper J
    Ann Rheum Dis; 2008 Sep; 67(9):1276-81. PubMed ID: 18006539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.